rs1201916615
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6BP7
The NM_001387283.1(SMARCA4):c.4761G>A(p.Ser1587Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000484 in 1,446,498 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S1587S) has been classified as Likely benign.
Frequency
Consequence
NM_001387283.1 synonymous
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.4761G>A | p.Ser1587Ser | synonymous_variant | Exon 34 of 36 | ENST00000646693.2 | NP_001374212.1 | |
SMARCA4 | NM_003072.5 | c.4665G>A | p.Ser1555Ser | synonymous_variant | Exon 33 of 35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.4761G>A | p.Ser1587Ser | synonymous_variant | Exon 34 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.4665G>A | p.Ser1555Ser | synonymous_variant | Exon 33 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.4671G>A | p.Ser1557Ser | synonymous_variant | Exon 33 of 35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.4575G>A | p.Ser1525Ser | synonymous_variant | Exon 33 of 35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.4575G>A | p.Ser1525Ser | synonymous_variant | Exon 32 of 34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.4575G>A | p.Ser1525Ser | synonymous_variant | Exon 32 of 34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.4572G>A | p.Ser1524Ser | synonymous_variant | Exon 33 of 35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.4086G>A | p.Ser1362Ser | synonymous_variant | Exon 30 of 32 | ENSP00000496004.1 | ||||
SMARCA4 | ENST00000644963.1 | c.3315G>A | p.Ser1105Ser | synonymous_variant | Exon 26 of 28 | ENSP00000495599.1 | ||||
SMARCA4 | ENST00000644065.1 | c.3297G>A | p.Ser1099Ser | synonymous_variant | Exon 25 of 27 | ENSP00000493615.1 | ||||
SMARCA4 | ENST00000642350.1 | c.3159G>A | p.Ser1053Ser | synonymous_variant | Exon 25 of 27 | ENSP00000495355.1 | ||||
SMARCA4 | ENST00000643857.1 | c.2925G>A | p.Ser975Ser | synonymous_variant | Exon 23 of 25 | ENSP00000494159.1 | ||||
SMARCA4 | ENST00000538456.4 | c.729G>A | p.Ser243Ser | synonymous_variant | Exon 6 of 8 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000452 AC: 1AN: 221202 AF XY: 0.00000834 show subpopulations
GnomAD4 exome AF: 0.00000484 AC: 7AN: 1446498Hom.: 0 Cov.: 32 AF XY: 0.00000278 AC XY: 2AN XY: 718426 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1Benign:1
- -
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Rhabdoid tumor predisposition syndrome 2 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at